AM630 is an inverse agonist at the human cannabinoid CB1 receptor

被引：46

作者：

Landsman, RS

Makriyannis, A

Deng, HF

Consroe, P

Roeske, WR

Yamamura, HI ^{[1
]}

机构：

[1] Univ Arizona, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA

[2] Univ Arizona, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA

[3] Univ Arizona, Hlth Sci Ctr, Dept Biochem, Tucson, AZ 85724 USA

[4] Univ Arizona, Hlth Sci Ctr, Dept Med, Tucson, AZ 85724 USA

[5] Univ Arizona, Hlth Sci Ctr, Dept Psychiat, Tucson, AZ 85724 USA

[6] Univ Arizona, Hlth Sci Ctr, Program Neurosci, Tucson, AZ 85724 USA

[7] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA

来源：

LIFE SCIENCES | 1998年 / 62卷 / 09期

关键词：

human cannabinoid CB1 receptor; inverse agonism; AM630; WIN 55,212-2; GTP gamma S; CHO cells; inverse agonist; negative intrinsic activity;

D O I：

10.1016/S0024-3205(97)01187-9

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The present investigation examines WIN 55,212-2 and AM630 at the cloned human cannabinoid CB1, receptor stably expressed in Chinese hamster ovary (CHO) cells. The effect of various concentrations of WIN 55,212-2 and AM630 on basal [S-35]GTP gamma S binding to cell membranes was determined. WIN 55,212-2 (100 mu M) stimulated basal [S-35]GTP gamma S binding 77.9% with an EC50 value of 0.36 mu M. Conversely, AM630 (100 mu M) inhibited basal [S-35]GTP gamma S binding by 20.9% with an EC50 value of 0.90 mu M These results show that WIN 55,212-2 is an agonist and AM630 is an inverse agonist in this system. (C) 1998 Elsevier Science Inc.

引用

页码：PL109 / PL113

页数：5

共 12 条

[1] A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - Evidence for a new model of receptor/ligand interactions
Bouaboula, M
Perrachon, S
Milligan, L
Canat, X
RinaldiCarmona, M
Portier, M
Barth, F
Calandra, B
Pecceu, F
Lupker, J
Maffrand, JP
LeFur, G
Casellas, P
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) : 22330 - 22339
[2] Compton DR, 1996, J PHARMACOL EXP THER, V277, P586
[3] COMPTON DR, 1992, J PHARMACOL EXP THER, V263, P1118
[4] AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain
Hosohata, K
Quock, RM
Hosohata, Y
Burkey, TH
Makriyannis, A
Consroe, P
Roeske, WR
Yamamura, HI
[J]. LIFE SCIENCES, 1997, 61 (09) : PL115 - PL118
[5] SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
Landsman, RS
Burkey, TH
Consroe, P
Roeske, WR
Yamamura, HI
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (01) : R1 - R2
[6] LOWRY OH, 1951, J BIOL CHEM, V193, P265
[7] PACHECO M, 1991, J PHARMACOL EXP THER, V257, P170
[8] AM630, A COMPETITIVE CANNABINOID RECEPTOR ANTAGONIST
PERTWEE, R
GRIFFIN, G
FERNANDO, S
LI, XY
HILL, A
MAKRIYANNIS, A
[J]. LIFE SCIENCES, 1995, 56 (23-24) : 1949 - 1955
[9] Further evidence for the presence of cannabinoid CBI receptors in guinea-pig small intestine
Pertwee, RG
Fernando, SR
Nash, JE
Coutts, AA
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) : 2199 - 2205
[10] SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice
Richardson, JD
Aanonsen, L
Hargreaves, KM
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 319 (2-3) : R3 - R4

← 1 2 →